Literature DB >> 23001021

Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum.

Ignacio Pascual-Castroviejo1, Samuel-Ignacio Pascual-Pascual.   

Abstract

INTRODUCTION: Neurofibromatosis type 1 (NF1), one of the most common neurocutaneous disorders, is a multisystemic disease associated with tumors in any organ of the body, especially in the central nervous system and also the peripheral nervous system. Pilocytic astrocytomas have been described in almost all intracranial regions in patients with NF1. However, only a few patients with NF1 and tumor of the corpus callosum have been reported to date.
MATERIAL AND METHODS: An 11-year-old white Spanish boy was evaluated due to a family history of NF1 and low performance test scores in school. He was studied from the neurological and intellectual level points of view.
RESULTS: Magnetic resonance (MR) study revealed a tumor in the anterior-middle portion of the corpus callosum and a Wechsler Intelligence Scale for Children-Revised showed verbal IQ of 92, a performance IQ of 108, and a total IQ of 100. In addition, he showed attention deficit and hyperactivity disorder.
CONCLUSIONS: Tumors of corpus callosum in patients with NF1 are very uncommon. The patient presented in this paper consulted due to family history of NF1, progressive hyperactivity, and below average school performance. The MR study showed tumor in the corpus callosum. Tumor histology was not investigated.

Entities:  

Mesh:

Year:  2012        PMID: 23001021     DOI: 10.1007/s00381-012-1903-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  28 in total

Review 1.  Neurofibromatosis-Noonan syndrome.

Authors:  J C Carey
Journal:  Am J Med Genet       Date:  1998-01-23

2.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

3.  Neurofibromatosis: implications for learning and behavior.

Authors:  M J Eliason
Journal:  J Dev Behav Pediatr       Date:  1986-06       Impact factor: 2.225

4.  Treatment of ADHD in neurofibromatosis type 1.

Authors:  Victor-F Mautner; Lan Kluwe; Sarang D Thakker; Robert A Leark
Journal:  Dev Med Child Neurol       Date:  2002-03       Impact factor: 5.449

5.  Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.

Authors:  Shelley L Hyman; E Arthur Shores; Kathryn N North
Journal:  Dev Med Child Neurol       Date:  2006-12       Impact factor: 5.449

6.  [Cerebral hemisphere tumours in neurofibromatosis type 1 during childhood].

Authors:  Ignacio Pascual-Castroviejo; Samuel Ignacio Pascual-Pascual; Juan Viaño; Ramón Velázquez-Fragua; Fernando Carceller-Benito; Manuel Gutiérrez-Molina; Carmen Morales-Bastos
Journal:  Rev Neurol       Date:  2010-04-16       Impact factor: 0.870

7.  Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.

Authors:  Ludwine Messiaen; Suxia Yao; Hilde Brems; Tom Callens; Achara Sathienkijkanchai; Ellen Denayer; Emily Spencer; Pamela Arn; Dusica Babovic-Vuksanovic; Carolyn Bay; Gary Bobele; Bruce H Cohen; Luis Escobar; Deborah Eunpu; Theresa Grebe; Robert Greenstein; Rachel Hachen; Mira Irons; David Kronn; Edmond Lemire; Kathleen Leppig; Cynthia Lim; Marie McDonald; Vinodh Narayanan; Amy Pearn; Robert Pedersen; Berkley Powell; Lawrence R Shapiro; David Skidmore; David Tegay; Heidi Thiese; Elaine H Zackai; Raymon Vijzelaar; Koji Taniguchi; Toranoshin Ayada; Fuyuki Okamoto; Akihiko Yoshimura; Annabel Parret; Bruce Korf; Eric Legius
Journal:  JAMA       Date:  2009-11-18       Impact factor: 56.272

8.  Lesions of the corpus callosum in children with neurofibromatosis 1.

Authors:  Aviva Mimouni-Bloch; Liora Kornreich; Walid Kaadan; Tamar Steinberg; Avinoam Shuper
Journal:  Pediatr Neurol       Date:  2008-06       Impact factor: 3.372

9.  Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.

Authors:  Hilde Brems; Magdalena Chmara; Mourad Sahbatou; Ellen Denayer; Koji Taniguchi; Reiko Kato; Riet Somers; Ludwine Messiaen; Sofie De Schepper; Jean-Pierre Fryns; Jan Cools; Peter Marynen; Gilles Thomas; Akihiko Yoshimura; Eric Legius
Journal:  Nat Genet       Date:  2007-08-19       Impact factor: 38.330

10.  Optic gliomas in children with neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; M J Greenwald; N B Esterly
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.